| 1 | [SID49647226] | Active | Potency | 19.9526 | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins [AID485364, Type: confirmatory] | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | Potency | 19.9526 [uM] | | BioAssay | qHTS Assay for the Inhibitors of Schistosoma Mansoni Peroxiredoxins | | AID | 485364 | | BioAssay type | confirmatory | | Target | thioredoxin glutathione reductase [Schistosoma mansoni] [gi:15149312] | | PubMed | | | Data Table |  |
|
| 2 | [SID49647226] | Active | | | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase [AID1556, Type: screening] | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Epi-absorbance primary biochemical high throughput screening assay to identify inhibitors of IMP-1 metallo-beta-lactamase | | AID | 1556 | | BioAssay type | screening | | Target | metallo-beta-lactamase IMP-1 [Pseudomonas aeruginosa] [gi:27368096] | | PubMed | | | Data Table |  |
|
| 3 | [SID49647226] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 4 | [SID49647226] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 5 | [SID49647226] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 6 | [SID49647226] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 7 | [SID49647226] | Active | | | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents [AID1835, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1835 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 8 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 9 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 10 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 11 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 12 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents [AID1511, Type: screening] | putative potassium channel subunit [Homo sapiens] [gi:487738] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that protect hERG from block by proarrhythmic agents | | AID | 1511 | | BioAssay type | screening | | Target | putative potassium channel subunit [Homo sapiens] [gi:487738] | | PubMed | | | Data Table |  |
|
| 13 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels [AID2648, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate/activate KCNQ1 potassium channels | | AID | 2648 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 14 | [SID49647226] | Active | | | Counter screen assay of the parental CHO cells for identification of compounds that potentiate KCNQ1 potassium channels [AID493006, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Counter screen assay of the parental CHO cells for identification of compounds that potentiate KCNQ1 potassium channels | | AID | 493006 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 15 | [SID49647226] | Active | | | Validation assay for identification of compounds that potentiate KCNQ1 potassium channels [AID493007, Type: screening] | KCNQ1 gene product [Homo sapiens] [gi:32479527] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Validation assay for identification of compounds that potentiate KCNQ1 potassium channels | | AID | 493007 | | BioAssay type | screening | | Target | KCNQ1 gene product [Homo sapiens] [gi:32479527] | | PubMed | | | Data Table |  |
|
| 16 | [SID49647226] | Active | | | KCNQ2 Counter screen for compounds that protect hERG from block by proarrhythmic agents [AID1942, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | KCNQ2 Counter screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1942 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 17 | [SID49647226] | Active | | | KCNQ2 Counter screen for compounds that protect hERG from block by proarrhythmic agents [AID1942, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | KCNQ2 Counter screen for compounds that protect hERG from block by proarrhythmic agents | | AID | 1942 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 18 | [SID49647226] | Active | | | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels [AID2287, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels | | AID | 2287 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 19 | [SID49647226] | Active | | | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels [AID2287, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Confirmatory screen for compounds that potentiate KCNQ2 potassium channels | | AID | 2287 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 20 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels [AID2239, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels | | AID | 2239 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 21 | [SID49647226] | Active | | | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels [AID2239, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that potentiate KCNQ2 potassium channels | | AID | 2239 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 22 | [SID49647226] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID1822, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 1822 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 23 | [SID49647226] | Active | | | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). [AID1822, Type: screening] | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | QFRET-based primary biochemical high throughput screening assay to identify inhibitors of the Plasmodium falciparum M18 Aspartyl Aminopeptidase (PFM18AAP). | | AID | 1822 | | BioAssay type | screening | | Target | M18 aspartyl aminopeptidase [Plasmodium falciparum 3D7] [gi:23505220] | | PubMed | | | Data Table |  |
|
| 24 | [SID49647226] | Active | | | Specificity screen assay against KCNQ2 for identification of compounds that potentiate KCNQ1 potassium channels [AID493009, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Specificity screen assay against KCNQ2 for identification of compounds that potentiate KCNQ1 potassium channels | | AID | 493009 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 25 | [SID49647226] | Active | | | Specificity screen assay against KCNQ2 for identification of compounds that potentiate KCNQ1 potassium channels [AID493009, Type: screening] | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Active | | BioAssay | Specificity screen assay against KCNQ2 for identification of compounds that potentiate KCNQ1 potassium channels | | AID | 493009 | | BioAssay type | screening | | Target | Kcnq2 gene product [Rattus norvegicus] [gi:18959272] | | PubMed | | | Data Table |  |
|
| 26 | [SID49647226] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 27 | [SID49647226] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 28 | [SID49647226] | Inactive | Potency | 10 | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide [AID1768, Type: confirmatory] | MEN1 gene product [Homo sapiens] [gi:18860839] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | 10 [uM] | | BioAssay | qHTS Assay for Inhibitors Targeting the Menin-MLL Interaction in MLL Related Leukemias: Competition With Texas Red Labeled MLL-derived Mutant Peptide | | AID | 1768 | | BioAssay type | confirmatory | | Target | MEN1 gene product [Homo sapiens] [gi:18860839] | | PubMed | | | Data Table |  |
|
| 29 | [SID49647226] | Inactive | Potency | 22.3872 | qHTS for Inhibitors of ATXN expression [AID651635, Type: confirmatory] | ATXN2 gene product [Homo sapiens] [gi:171543895] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS for Inhibitors of ATXN expression | | AID | 651635 | | BioAssay type | confirmatory | | Target | ATXN2 gene product [Homo sapiens] [gi:171543895] | | PubMed | | | Data Table |  |
|
| 30 | [SID49647226] | Inactive | Potency | 22.3872 | qHTS Assay for Inhibitors of Influenza NS1 Protein Function [AID2326, Type: confirmatory] | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS Assay for Inhibitors of Influenza NS1 Protein Function | | AID | 2326 | | BioAssay type | confirmatory | | Target | nonstructural protein 1 [Influenza A virus (A/WSN/1933(H1N1))] [gi:194352380] | | PubMed | | | Data Table |  |
|
| 31 | [SID49647226] | Inactive | Potency | 28.1838 | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction [AID2662, Type: confirmatory] | MLL gene product [Homo sapiens] [gi:56550039] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | 28.1838 [uM] | | BioAssay | qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction | | AID | 2662 | | BioAssay type | confirmatory | | Target | MLL gene product [Homo sapiens] [gi:56550039] | | PubMed | | | Data Table |  |
|
| 32 | [SID49647226] | Inactive | Potency | 35.4813 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | 35.4813 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 33 | [SID49647226] | Inactive | Potency | | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1721, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Inhibitors of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1721 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 34 | [SID49647226] | Inactive | Potency | | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) [AID1722, Type: confirmatory] | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS Assay for Activators of Leishmania Mexicana Pyruvate Kinase (LmPK) | | AID | 1722 | | BioAssay type | confirmatory | | Target | pyruvate kinase [Leishmania mexicana mexicana] [gi:290753097] | | PubMed | | | Data Table |  |
|
| 35 | [SID49647226] | Inactive | | | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity [AID504423, Type: screening] | LANA [Human herpesvirus 8] [gi:312275222] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | C-LANA FP assay Measured in Biochemical System Using Plate Reader - 2117-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504423 | | BioAssay type | screening | | Target | LANA [Human herpesvirus 8] [gi:312275222] | | PubMed | | | Data Table |  |
|
| 36 | [SID49647226] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 37 | [SID49647226] | Inactive | | | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) [AID588664, Type: screening] | ABL1 gene product [Homo sapiens] [gi:62362414] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | TRFRET-based biochemical primary high throughput screening assay to identify inhibitors of the interaction of the Ras and Rab interactor 1 protein (Rin1) and the c-abl oncogene 1, non-receptor tyrosine kinase (Abl) | | AID | 588664 | | BioAssay type | screening | | Target | ABL1 gene product [Homo sapiens] [gi:62362414] | | PubMed | | | Data Table |  |
|
| 38 | [SID49647226] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 39 | [SID49647226] | Inactive | | | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay [AID651560, Type: screening] | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule inhibitors of Low Molecular Weight Protein Tyrosine Phosphatase, LMPTP, via a fluorescence intensity assay | | AID | 651560 | | BioAssay type | screening | | Target | Low molecular weight phosphotyrosine protein phosphatase [gi:1709543] | | PubMed | | | Data Table |  |
|
| 40 | [SID49647226] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 41 | [SID49647226] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 42 | [SID49647226] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 43 | [SID49647226] | Inactive | | | HTS for Beta-2AR agonists via FAP method [AID504454, Type: screening] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | HTS for Beta-2AR agonists via FAP method | | AID | 504454 | | BioAssay type | screening | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 44 | [SID49647226] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 45 | [SID49647226] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 46 | [SID49647226] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 47 | [SID49647226] | Inactive | Potency | | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor [AID492947, Type: confirmatory] | ADRB2 gene product [Homo sapiens] [gi:4501969] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS assay of beta-arrestin-biased ligands of beta2-adrenergic receptor | | AID | 492947 | | BioAssay type | confirmatory | | Target | ADRB2 gene product [Homo sapiens] [gi:4501969] | | PubMed | | | Data Table |  |
|
| 48 | [SID49647226] | Inactive | | | RNA aptamer-based HTS for inhibitors of GRK2 [AID488847, Type: screening] | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | RNA aptamer-based HTS for inhibitors of GRK2 | | AID | 488847 | | BioAssay type | screening | | Target | beta-adrenergic receptor kinase 1 [Homo sapiens] [gi:148539876] | | PubMed | | | Data Table |  |
|
| 49 | [SID49647226] | Inactive | | | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay [AID2520, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2520 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|
| 50 | [SID49647226] | Inactive | | | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay [AID2520, Type: screening] | APLNR gene product [Homo sapiens] [gi:4885057] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 49647226 | | CID | 23736052 | | Outcome | Inactive | | BioAssay | uHTS identification of small molecule agonists of the APJ receptor via a luminescent beta-arrestin assay | | AID | 2520 | | BioAssay type | screening | | Target | APLNR gene product [Homo sapiens] [gi:4885057] | | PubMed | | | Data Table |  |
|